Bioretec was granted CE Mark approval for two bioresorbable devices, the Activa IM-Nail™ and the ActivaScrew™ Interference TCP screw.
Activa IM-Nail is reportedly the first fully-bioabsorbable option for pediatric forearm intramedullary nailing. The device offers an economical solution for hospitals, as it obviates the need for implant removal.
Activa IM-Nail is made of self-reinforced PLGA with an osteoconductive tricalcium-phosphate marker in the tip, allowing faster mini-invasive navigation with enhanced implant visibility in the x-ray. Shorter versions of the device are suitable for intramedullary distal radius and ulna fracture fixations.
The company also received approval under the CE Mark for ActivaScrew™ Interference TCP for ligament fixation, reportedly the smallest biocomposite interference screw on the market. ActivaScrew uses Bioretec´s Self-Locking SL™ technology that allows the implant to expand in diameter by 1% to 2% in the body, adding to secure fixation.
Bioretec products are sold in over 35 countries worldwide. The company is developing materials and product lines for high load-bearing clinical applications based on new materials and composites. A next-generation bioresorbable metal, RemeOs™, is in clinical testing with promising interim results. RemeOs is based on naturally-occurring metals in the human body, magnesium, zinc and calcium.
Bioretec was granted CE Mark approval for two bioresorbable devices, the Activa IM-Nail™ and the ActivaScrew™ Interference TCP screw.
Activa IM-Nail is reportedly the first fully-bioabsorbable option for pediatric forearm intramedullary nailing. The device offers an economical solution for hospitals, as it obviates the need for implant...
Bioretec was granted CE Mark approval for two bioresorbable devices, the Activa IM-Nail™ and the ActivaScrew™ Interference TCP screw.
Activa IM-Nail is reportedly the first fully-bioabsorbable option for pediatric forearm intramedullary nailing. The device offers an economical solution for hospitals, as it obviates the need for implant removal.
Activa IM-Nail is made of self-reinforced PLGA with an osteoconductive tricalcium-phosphate marker in the tip, allowing faster mini-invasive navigation with enhanced implant visibility in the x-ray. Shorter versions of the device are suitable for intramedullary distal radius and ulna fracture fixations.
The company also received approval under the CE Mark for ActivaScrew™ Interference TCP for ligament fixation, reportedly the smallest biocomposite interference screw on the market. ActivaScrew uses Bioretec´s Self-Locking SL™ technology that allows the implant to expand in diameter by 1% to 2% in the body, adding to secure fixation.
Bioretec products are sold in over 35 countries worldwide. The company is developing materials and product lines for high load-bearing clinical applications based on new materials and composites. A next-generation bioresorbable metal, RemeOs™, is in clinical testing with promising interim results. RemeOs is based on naturally-occurring metals in the human body, magnesium, zinc and calcium.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
